Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2023. Start Trial.
Date Value
November 16, 2026 1.890
November 13, 2026 1.892
November 12, 2026 1.858
November 11, 2026 1.885
November 10, 2026 1.880
November 09, 2026 1.922
November 06, 2026 1.855
November 05, 2026 1.692
November 04, 2026 1.803
November 03, 2026 1.890
November 02, 2026 1.910
October 30, 2026 2.046
October 29, 2026 2.041
October 28, 2026 1.976
October 27, 2026 1.939
October 26, 2026 1.971
October 23, 2026 1.956
October 22, 2026 2.004
October 21, 2026 1.949
October 20, 2026 1.855
October 19, 2026 1.813
October 16, 2026 1.806
October 15, 2026 1.833
October 14, 2026 1.776
October 13, 2026 1.887
Date Value
October 12, 2026 1.952
October 09, 2026 2.066
October 08, 2026 2.145
October 07, 2026 2.105
October 06, 2026 2.160
October 05, 2026 2.12
October 02, 2026 2.162
October 01, 2026 2.170
September 30, 2026 2.313
September 29, 2026 2.073
September 28, 2026 2.057
September 25, 2026 2.105
September 24, 2026 2.136
September 23, 2026 2.268
September 22, 2026 2.432
September 21, 2026 2.302
September 18, 2026 2.302
September 17, 2026 2.266
September 16, 2026 2.250
September 15, 2026 2.286
September 14, 2026 2.406
September 11, 2026 2.397
September 10, 2026 2.568
September 09, 2026 2.604
September 08, 2026 2.761

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Novartis AG 8.070
Roche Holding AG --
Addex Therapeutics Ltd. 1.659
Sandoz Group AG --
Galderma Group AG --

Price to Book Value Related Metrics

Price 7.56
Earnings Yield -22.75%
Market Cap 468.11M